Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
<p>Abstract</p> <p>Background</p> <p>In clinical practice, physicians often need to change the antipsychotic medications they give to patients because of an inadequate response or the presence of unacceptable or unsafe side effects. However, there is a lack of consensus...
Main Authors: | Berry Sally A, Mahmoud Ramy, Brar Jaspreet S, Ganguli Rohan, Pandina Gahan J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-06-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/6/17 |
Similar Items
-
An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012-06-01) -
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
by: Adel Gabriel
Published: (2010-10-01) -
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
by: Wu Jasmanda, et al.
Published: (2009-02-01) -
The evaluations of risperidone and olanzapine in the treatment of schizophrenia disorders
by: Shu-Ling Chang, et al.
Published: (2010) -
A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
by: Saeed Shoja Shafti, et al.
Published: (2014-01-01)